Lawyers Seek to Restore Investors' Losses and Confidence in Affymax, Announces Deans & Lyons Law Firm LLP

DALLAS--(BUSINESS WIRE)--Deans & Lyons LLP securities lawyers announced potential claims on behalf of shareholders of Affymax (NASDAQ: AFFY) who purchased or acquired stock from December 8, 2011 until February 22, 2013. Concerned AFFY investors with stock losses are encouraged to contact attorney Hamilton Lindley at 877-819-8033 or [e-mail] about their rights and remedies.

“The shareholder lawsuits, filed in the Northern District of California, seek to compensate investors for their losses and require better corporate governance from company management.”

“Following a report that the FDA was requiring a recall of the company’s lead drug, due to reports of ‘serious and life-threatening’ allergic reactions, shares of Affymax declined 85%,” said shareholder rights lawyer Hamilton Lindley. “The shareholder lawsuits, filed in the Northern District of California, seek to compensate investors for their losses and require better corporate governance from company management.”

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. AFFY stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at [e-mail] or 877-819-8033 with questions or concerns.